Want to see JP:4202 full AI Analyst Report?
Top Page
Daicel
(4202)
Select Model
Select Model
Rating:58Neutral
Price Target:
¥1,524.00
▲(5.43% Upside)
Action:Reiterated
Date:08/23/26
The score is mainly held back by weaker recent profitability and inconsistent free cash flow despite steady revenue growth and a gradually improving balance sheet. Technicals are mildly supportive with neutral momentum, while valuation is mixed—an attractive dividend yield offset by a high P/E.
Positive Factors
Steady Revenue Growth
Multi-year top-line growth supports a durable demand base across Daicel’s chemical and engineered-product businesses. Continued positive revenue in the latest annual period indicates customer programs and market reach remain intact despite weaker profitability.
Negative Factors
Profitability Deterioration
Latest-year net income fell sharply and operating profit compressed, showing that revenue growth is not converting reliably into earnings. Persistent margin pressure could constrain reinvestment and increase sensitivity to product mix and input costs.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady Revenue Growth
Multi-year top-line growth supports a durable demand base across Daicel’s chemical and engineered-product businesses. Continued positive revenue in the latest annual period indicates customer programs and market reach remain intact despite weaker profitability.
Read all positive factors
Daicel (4202) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥372.04B
Dividend Yield4.11%
Average Volume (3M)536.76K
Price to Earnings (P/E)37.3
Beta (1Y)0.95
Revenue Growth2.16%
EPS Growth-77.64%
CountryJP
Employees11,034
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)39.11
Shares Outstanding256,142,670
10 Day Avg. Volume480,400
30 Day Avg. Volume536,760
Financial Highlights & Ratios
PEG Ratio-0.40
Price to Book (P/B)0.91
Price to Sales (P/S)0.56
P/FCF Ratio128.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥1,500.00Price Target Upside3.77% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)128.08
Revenue Forecast (FY)¥610.06B
Daicel Business Overview & Revenue Model
Company Description
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic de...
How the Company Makes Money
Daicel makes money primarily by manufacturing and selling chemicals, advanced materials, and engineered products to business customers (B2B) across multiple end markets. Revenue is largely generated through (1) sales of specialty/functional chemic...
Daicel Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
58
Neutral
Cash Flow
52
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 592.74B | 579.63B | 586.53B | 558.06B | 538.03B | 467.94B |
| Gross Profit | 148.15B | 146.29B | 165.84B | 160.39B | 147.04B | 139.68B |
| EBITDA | 73.35B | 72.71B | 108.86B | 111.40B | 87.97B | 75.84B |
| Net Income | 9.92B | 10.18B | 49.48B | 55.84B | 40.68B | 31.25B |
Balance Sheet | ||||||
| Total Assets | 865.29B | 833.93B | 813.83B | 839.17B | 765.61B | 698.84B |
| Cash, Cash Equivalents and Short-Term Investments | 73.03B | 68.81B | 65.14B | 73.18B | 93.84B | 90.53B |
| Total Debt | 310.77B | 304.25B | 286.12B | 304.12B | 321.97B | 283.55B |
| Total Liabilities | 481.94B | 463.55B | 438.79B | 464.30B | 455.17B | 419.29B |
| Stockholders Equity | 367.86B | 355.60B | 359.99B | 358.90B | 295.21B | 272.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.51B | 23.44B | 11.11B | -20.54B | -501.00M |
| Operating Cash Flow | 0.00 | 67.84B | 93.41B | 76.73B | 26.85B | 42.99B |
| Investing Cash Flow | 0.00 | -49.26B | -47.87B | -55.37B | -36.89B | -46.53B |
| Financing Cash Flow | 0.00 | -21.26B | -48.85B | -52.37B | 12.76B | -5.45B |
Daicel Technical Analysis
Positive
1445.50
Price Trends
1426.32
Positive
1337.91
Positive
1357.84
Positive
Market Momentum
9.37
Positive
51.33
Neutral
51.69
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4202, the sentiment is Positive. The current price of 1445.5 is below the 20-day moving average (MA) of 1461.45, above the 50-day MA of 1426.32, and above the 200-day MA of 1357.84, indicating a neutral trend. The MACD of 9.37 indicates Positive momentum. The RSI at 51.33 is Neutral, neither overbought nor oversold. The STOCH value of 51.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4202.
Daicel Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥368.97B | 10.52 | 6.43% | 2.74% | 3.53% | 63.85% | |
77 Outperform | ¥459.58B | 11.23 | 9.96% | 3.43% | 0.17% | 69.59% | |
69 Neutral | ¥605.93B | 20.99 | 8.52% | 1.62% | 10.34% | 64.18% | |
67 Neutral | ¥344.57B | 14.52 | 5.75% | 3.31% | 2.52% | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | ¥372.04B | 37.29 | 2.75% | 4.15% | 2.16% | -77.64% | |
50 Neutral | ¥743.19B | -24.78 | -6.25% | 2.29% | 2.69% | -173.16% |
* Basic Materials Sector Average
JP:4202
Daicel
1,458.50
148.03
11.30%
JP:4118
Kaneka
6,135.00
1,921.88
45.62%
JP:4182
Mitsubishi Gas Chemical Company
3,870.00
1,252.22
47.84%
JP:4208
UBE Industries
3,542.00
1,297.43
57.80%
JP:4205
Zeon
2,414.00
776.15
47.39%
JP:4203
Sumitomo Bakelite Co., Ltd.
7,540.00
2,609.73
52.93%
Daicel Corporate Events
Daicel Lowers EBITDA Growth Target in Revised Mid-Term Strategy
May 25, 2026
Daicel Corporation has issued corrections to its recently announced mid-term management strategy, Accelerate 2030, adjusting a key performance target for its growth portfolio. The company revised its EBITDA growth goal for the period from the fisc...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.